NorthCoast Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$26.4M Buy
244,798
+234,196
+2,209% +$26.8M 0.96% 28
2021
Q2
$1.2M Sell
10,602
-7,868
-43% -$886K 0.04% 235
2021
Q1
$2M Sell
18,470
-2,688
-13% -$288K 0.08% 165
2020
Q4
$2.27M Sell
21,158
-249
-1% -$23.9K 0.1% 129
2020
Q3
$1.88M Buy
21,407
+2,980
+16% +$281K 0.1% 127
2020
Q2
$1.81M Buy
18,427
+3,181
+21% +$280K 0.1% 123
2020
Q1
$1.16M Buy
+15,246
New +$1.3M 0.07% 141
2019
Q3
Sell
-4,229
Closed -$308K 226
2019
Q2
$308K Buy
4,229
+1,029
+32% +$80.9K 0.02% 233
2019
Q1
$258K Buy
+3,200
New +$262K 0.02% 224

Other funds holding ABBV

NorthCoast Asset Management's ABBV Position: Q3 2021 in Review

NorthCoast Asset Management increased its AbbVie (ABBV) stake by 2,209% in Q3 2021, buying an estimated $26.8M and bringing the position to 244,798 shares worth $26.4M. The position accounts for 0.96% of the portfolio, ranked #28.

NorthCoast Asset Management first reported a position in ABBV in Q1 2019 and has held it in 9 quarters since. 2,655 funds tracked by Wall St. Rank hold ABBV as of Q3 2021.

  • NorthCoast Asset Management held 244,798 shares of AbbVie worth $26.4M as of Q3 2021.
  • NorthCoast Asset Management bought 234,196 AbbVie shares in Q3 2021, an estimated $26.8M.
  • AbbVie made up 0.96% of NorthCoast Asset Management's portfolio in Q3 2021, its #28 holding.
  • NorthCoast Asset Management first reported a position in AbbVie in Q1 2019 and has held it in 9 quarters since.
  • 2,655 funds tracked by Wall St. Rank held AbbVie as of Q3 2021.

Based on NorthCoast Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.